Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-Choline for guiding target volume delineation.

The aim of this study was to report the first cases of salvage radiotherapy using the Intensity-Modulated Radiotherapy (IMRT) with Simultaneous Integrated Boost (SIB) targeted on choline PET uptake in a local recurrent prostate cancer, after a radical prostatectomy.

4 patients received salvage irradiation for biochemical relapse that occurred after the initial radical prostatectomy. The relapse occurred from 10 months to 6 years with PSA levels ranging from 2. 35 to 4. 86 ng/ml. For each patient, a (18)F-Choline PET-CT showed a focal choline uptake in prostatic fossa, with standardized uptake value calculated on the basis of predicted lean body mass (SUL) max of 3. 3-6. 8. No involved lymph node or distant metastases were diagnosed. IMRT doses were of 62. 7 Gy (1. 9 Gy/fraction, 33 fractions), with a SIB of 69. 3 Gy (2,1 Gy/fraction, 33 fractions) to a PET-guided target volume.

Acute toxicities were limited. We observed no gastrointestinal toxicity ≥grade 2 and only one grade 2 genitourinary toxicity. At one month follow-up evaluation, no complication and a decrease in PSA level (6. 8% to 43. 8% of the pre-therapeutic leve) were reported. After 4 months, a decrease in PSA level was obtained for all the patients, ranging from 30 to 70%. At a median follow up of 15 months, PSA level was controlled for all the patients, but one of them experienced a distant lymph node recurrence.

Salvage irradiation to the prostate bed with SIB guided by PET-CT is feasible, with biological efficacy and no major acute toxicity. Advance in knowledge: IMRT with PET oriented SIB for salvage treatment of prostate cancer is possible, without major acute toxicity.

The British journal of radiology. 2015 Dec 09 [Epub ahead of print]

Aurélien Wahart, Jean-Baptiste Guy, Alexis Vallard, Benjamin Geissler, Majed Ben Mrad, Alexander T Falk, Nathalie Prevot, Guy de Laroche, Chloé Rancoule, Cyrus Chargari, Nicolas Magné

1 Department of Radiotherapy, Institut de cancérologie de la Loire - Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France. , 1 Department of Radiotherapy, Institut de cancérologie de la Loire - Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France. , 1 Department of Radiotherapy, Institut de cancérologie de la Loire - Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France. , 3 Centre d'Imagerie Nucléaire, Hôpital Privé de la Loire, Saint Etienne, France. , 1 Department of Radiotherapy, Institut de cancérologie de la Loire - Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France. , 4 Department of Radiotherapy, Centre Antoine Lacassagne, Nice, France. , 2 Department of Nuclear Medicine, Hôpital Nord, CHU de Saint Etienne, France. , 1 Department of Radiotherapy, Institut de cancérologie de la Loire - Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France. , 1 Department of Radiotherapy, Institut de cancérologie de la Loire - Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France. , 5 Radiation Oncology, Hôpital d'Instruction des Armées du Val-de-Grâce, Paris, France. , 1 Department of Radiotherapy, Institut de cancérologie de la Loire - Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe